Hikma Pharmaceuticals holds the cleaner structural position, with the lead spread across valuation and growth. Straumann still has the edge on profitability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Straumann, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Hikma Pharmaceuticals, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.
The lead is spread across valuation and growth, rather than sitting in one isolated gap. The overall score gap is 21 points in favour of Hikma Pharmaceuticals PLC.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The match is driven mainly by capital structure and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Hikma Pharmaceuticals PLC looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The multiple-based pricing edge comes from a forward P/E that is 20.5 turns lower.
Profitability still favours Straumann, with a 7.6-point operating margin advantage keeping the comparison from looking fully resolved.
The lead is built on both valuation and growth — though profitability still provides a counterweight.
Break down the HIK.L vs STMN.SW comparison across all dimensions with the full interactive tool.
Explore how HIK.L and STMN.SW each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.